共 50 条
- [41] Anticitrulline antibody assay specificity for rheumatoid arthritis: comment on the article by Schellekens et al - Reply ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1902 - 1902
- [42] Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1782 - 1782
- [43] Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et al Reply ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3645 - 3646
- [45] Diagnostic value of Doppler ultrasonography in rheumatoid arthritis: comment on the article by Weidekamm et al - Reply ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 677 - 678
- [46] Persistent efficacy of tumor necrosis factor α blockage therapy in SAPHO syndrome:: comment on the article by Wagner et al -: Reply ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1467 - 1468
- [47] Heterogeneity of tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Siebert et al - Reply ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2952 - 2953
- [48] Effects of anti-tumor necrosis factor α on synovium in patients with spondylarthropathy:: Comment on the article by Baeten et al -: Reply ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2938 - 2939
- [49] Tumor necrosis factor a microsatellite polymorphism in rheumatoid arthritis: Comment ARTHRITIS AND RHEUMATISM, 1997, 40 (07): : 1368 - 1369
- [50] Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor α-blocking agent:: Comment on the article by Pisetsky and the letter from Aringer et al -: Reply ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1409 - 1409